HLA-A and cancer: By contrast, in most mice treated with either Co-STAR-2 or Co-TCR T cells, most of which succumbed to their tumors earlier than those treated with Co-STAR-1 T cells, the circulating cancer cells retained the expression of HLA-A*02:01 on their surface.